Development of a Patient-Reported Outcome (PRO) Measure to Assess Emotional Impact of Treatment for Type  2 Diabetes

ConclusionThe EIDTQ-Status and Comparison measures can be used as a supplement to clinical outcomes, such as hemoglobin A1c (HbA1c) and body weight, to provide a broader picture of the patient ’s emotional experience with medication treatment for T2D.
Source: Diabetes Therapy - Category: Endocrinology Source Type: research